Rapidity of Onset of Response to Adalimumab in Luminal Crohn's Disease (RAPIDA Study)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT02148718

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:36:39.932070+00:00

Published At

2017-08-29T00:00:00+00:00

Record Updated At

2018-03-01

Results Posted At

2017-08-29

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Moderate to Severe Crohn\u0027s Disease"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2018-03-01"

protocolSection.identificationModule.nctId

"NCT02148718"

protocolSection.identificationModule.officialTitle

"Rapidity of Onset of Response to Adalimumab in Luminal Crohn\u0027s Disease (RAPIDA Study)"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

["PHASE4"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

"2017-08-29"

Study condition terms

• Moderate to Severe Crohn's Disease (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.